Based on published literature and extensive research that we conducted on symptomatic and asymptomatic patients and a variety of pulmonary upper tract diseases and infection, Breath of Health has been able to identify the specific COVID19 markers
Detection of SARS-CoV-2 infection by exhaled breath spectral analysis: Introducing a ready-to-use point-ofcare mass screening methodBreath of Health assuccessfully conducted clinical trials for COVID-19, which have been approved by the Israeli Ministry of Health at Shiba Tel and Hospitals.
The present application claims the benefits of priority of US Provisional